Baillie Gifford Discloses 9.89% Stake in Guardant Health
Ticker: GH · Form: SC 13G · Filed: 2024-01-29T00:00:00.000Z
Sentiment: bullish
Topics: institutional-ownership, insider-buy, investment-firm, stake-disclosure
TL;DR
**Baillie Gifford just revealed a huge 9.89% stake in Guardant Health, signaling big institutional confidence.**
AI Summary
Baillie Gifford & Co, a prominent investment management firm, reported on January 29, 2024, that as of December 29, 2023, they beneficially own 10,240,637 shares of Guardant Health, Inc. (GH). This represents 9.89% of Guardant Health's common stock. This significant stake indicates Baillie Gifford's strong conviction in Guardant Health's future, which could signal confidence to other investors and potentially influence the stock's perception.
Why It Matters
A major institutional investor like Baillie Gifford taking a nearly 10% stake can be seen as a vote of confidence, potentially attracting more investor interest and supporting the stock price.
Risk Assessment
Risk Level: low — This filing indicates a significant institutional investment, generally viewed as a positive sign rather than a risk.
Analyst Insight
A smart investor would view this as a positive signal, potentially researching Guardant Health further to understand Baillie Gifford's investment thesis and consider adding to or initiating a position.
Key Numbers
- 10,240,637 — Shares Owned (Total shares of Guardant Health, Inc. beneficially owned by Baillie Gifford & Co.)
- 9.89% — Ownership Percentage (Percentage of Guardant Health, Inc.'s common stock owned by Baillie Gifford & Co.)
Key Players & Entities
- Baillie Gifford & Co (company) — the reporting person and investment management firm
- Guardant Health, Inc. (company) — the subject company whose securities are being reported
- 10,240,637 (dollar_amount) — number of shares beneficially owned by Baillie Gifford & Co
- 9.89% (dollar_amount) — percentage of Guardant Health's common stock owned by Baillie Gifford & Co
- December 29, 2023 (person) — date of the event requiring the filing
- January 29, 2024 (person) — date the SC 13G filing was made
Forward-Looking Statements
- Guardant Health's stock price may see increased stability or upward pressure due to institutional confidence. (Guardant Health, Inc.) — medium confidence, target: next 3-6 months
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is Baillie Gifford & Co, an investment management firm based in Edinburgh, Scotland, as indicated by the 'FILED BY' section and their business address.
What is the subject company whose shares are being reported?
The subject company is Guardant Health, Inc., a medical laboratories company with its business address at 3100 Hanover Street, Palo Alto, CA, as stated in the 'SUBJECT COMPANY' section.
How many shares of Guardant Health, Inc. does Baillie Gifford & Co beneficially own?
Baillie Gifford & Co beneficially owns 10,240,637 shares of Guardant Health, Inc. common stock, as detailed in the filing's summary of beneficial ownership.
What percentage of Guardant Health, Inc.'s common stock does Baillie Gifford & Co own?
Baillie Gifford & Co owns 9.89% of Guardant Health, Inc.'s common stock, as reported in the filing.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 29, 2023, as specified on the cover page of the Schedule 13G.
From the Filing
0001088875-24-000033.txt : 20240129 0001088875-24-000033.hdr.sgml : 20240129 20240129100022 ACCESSION NUMBER: 0001088875-24-000033 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-90826 FILM NUMBER: 24570952 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAILLIE GIFFORD & CO CENTRAL INDEX KEY: 0001088875 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: CALTON SQUARE STREET 2: 1 GREENSIDE ROW CITY: EDINBURGH STATE: X0 ZIP: EH13AN BUSINESS PHONE: 00441312752000 MAIL ADDRESS: STREET 1: CALTON SQUARE STREET 2: 1 GREENSIDE ROW CITY: EDINBURGH STATE: X0 ZIP: EH13AN SC 13G 1 Guardant29122023.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Guardant Health, Inc. ----------------------------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------------------------- (Title of Class of Securities) 40131M109 ----------------------------------------------------------------------- (CUSIP Number) 29 December 2023 ----------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1745 (3-06) CUSIP No. 40131M109 _______________________________________________________________________ 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 6,133,067 Shares Bene ______________________________________________________ ficially by 6. Shared Voting Power 0 Owned by Each ______________________________________________________ Reporting 7. Sole Dispositive Power 6,178,812 Person With: ______________________________________________________ 8. Shared Dispositive Power 0 _____________________